About ArthroCare (NASDAQ:ARTC)
ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.
Industry, Sector and Symbol
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
ArthroCare (NASDAQ:ARTC) Frequently Asked Questions
What is ArthroCare's stock symbol?
ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."
Who are ArthroCare's key executives?
ArthroCare's management team includes the folowing people:
- Gayle Wiley, Chief Human Resource Officer, Senior Vice President
- Jean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)
- Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)
- Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)
- Fred B. Dinger III, Senior Vice President, General Manager of ENT
- James L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)
- Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)
- Fabiana Lacerca-Allen, Independent Director (Age 47)
Has ArthroCare been receiving favorable news coverage?
News headlines about ARTC stock have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ArthroCare earned a coverage optimism score of 0.08 on Accern's scale. They also assigned news headlines about the medical device company an impact score of 44.88 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of ArthroCare?
Shares of ARTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact ArthroCare?
ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900.
MarketBeat Community Rating for ArthroCare (ARTC)MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe ARTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARTC will underperform the S&P 500 over the long term. You may vote once every thirty days.